Orna
Founded 2019 · 114 employees on LinkedIn · 3 known investors
Orna Therapeutics develops RNA and lipid nanoparticle (LNP) based therapies for treating diseases including oncology and cell therapy applications. The company leverages proprietary drug development expertise in oRNA and LNP technology platforms.
Founders & leadership
JB
Joe BolenChief Executive Officer
JB
Joe Bolen, Ph.D.Chief Executive Officer
HD
Hope D'Oyley-Gay, JDChief Legal Officer
CL
Ciaran Lawlor, Ph.D.Chief Operating Officer
FN
Frank Neumann, M.D., Ph.D.Chief Medical Officer
SS
Siva SakhamuriChief Technology Officer
BS
Investors · 3
Competitors · 5
by search overlap
ロゴマーク：AIRNA52 shared keywordsAIRNA develops RNA editing therapeutics aimed at providing functional cures for patients with rare diseases and common conditions. The company works in the genetic medicines and biotech space.
Ronatherapeutics48 shared keywordsRona Therapeutics develops siRNA-based therapeutics using its GAIA platform to target metabolic and cardiovascular conditions including hypertriglyceridemia, obesity, ASCVD, and MASH. Its pipeline includes APOC3, INHBE, PCSK9-Lp(a), and angiotensinogen-targeting candidates for patients with cardiovascular and metabolic diseases.
Avernatx46 shared keywordsAverna Therapeutics is a biotechnology company developing therapeutics. The page is a team bio profiling its CEO and board member.
Transcode Therapeutics44 shared keywordsTransCode Therapeutics is a clinical-stage company developing immuno-oncology and RNA-based therapeutics for high-risk and advanced cancers. Its lead candidate, TTX-MC138, targets microRNA-10b to treat patients with metastatic cancer and is in Phase 2a clinical trials.
Innorna43 shared keywordsInnorna develops mRNA-based therapeutics built on a proprietary platform featuring a lipid library of over 100,000 ionizable lipid structures and targeted LNP delivery systems. The company's pipeline spans vaccines, protein replacement therapies for chronic metabolic diseases, and in vivo immunotherapies for autoimmune conditions, with four candidates in clinical trials.
Companies competing with Orna for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Orna do?
- Orna Therapeutics develops RNA and lipid nanoparticle (LNP) based therapies for treating diseases including oncology and cell therapy applications. The company leverages proprietary drug development expertise in oRNA and LNP technology platforms.
- Who are Orna's investors?
- Orna's investors include Astellas Venture Management LLC, MPM BioImpact, Taiho Ventures, LLC.